Abstract
Hydroxamic acids attracted much attention due to their ability to coordinate a range of transition metal ions. Siderophores can be highlighted due to their role as iron carriers in biological systems. This chelation ability joined to their occurrence in living organisms lead to their possible use as drugs. One of the most important pharmacological properties is their ability to inhibit enzymes, activity that can give them properties such as antiinflammatory and anti-cancer agents. Another important feature resulting from their ability to form stable chelates is their use as ligands in asymmetric synthesis. In this review, we will discuss the most recent published results covering the above mentioned aspects.
Keywords: Biological activities, histone deacetylases, hydroxamic acids, metalloenzyme inhibitors, stereoselectivity, synthetic pathways.
Graphical Abstract
Current Organic Synthesis
Title:Hydroxamic Acids, Recent Breakthroughs in Stereoselective Synthesis and Biological Evaluations
Volume: 13 Issue: 5
Author(s): Diana C.G.A. Pinto and Artur M.S. Silva
Affiliation:
Keywords: Biological activities, histone deacetylases, hydroxamic acids, metalloenzyme inhibitors, stereoselectivity, synthetic pathways.
Abstract: Hydroxamic acids attracted much attention due to their ability to coordinate a range of transition metal ions. Siderophores can be highlighted due to their role as iron carriers in biological systems. This chelation ability joined to their occurrence in living organisms lead to their possible use as drugs. One of the most important pharmacological properties is their ability to inhibit enzymes, activity that can give them properties such as antiinflammatory and anti-cancer agents. Another important feature resulting from their ability to form stable chelates is their use as ligands in asymmetric synthesis. In this review, we will discuss the most recent published results covering the above mentioned aspects.
Export Options
About this article
Cite this article as:
Pinto C.G.A. Diana and Silva M.S. Artur, Hydroxamic Acids, Recent Breakthroughs in Stereoselective Synthesis and Biological Evaluations, Current Organic Synthesis 2016; 13 (5) . https://dx.doi.org/10.2174/1570179412666150914201333
DOI https://dx.doi.org/10.2174/1570179412666150914201333 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
CTLA-4Ig: Uses and Future Directions
Recent Patents on Inflammation & Allergy Drug Discovery Protein Kinase C Isozymes as Potential Targets for Anticancer Therapy
Current Cancer Drug Targets Recent Advances of Kinesin Motor Inhibitors and their Clinical Progress
Reviews on Recent Clinical Trials Bitter Gourd (Momordica charantia) is a Cornucopia of Health: A Review of its Credited Antidiabetic, Anti-HIV, and Antitumor Properties
Current Molecular Medicine The Benefits and Side Effects of Bevacizumab for the Treatment of Recurrent Ovarian Cancer
Current Drug Targets Traditional Chinese Medicine Remedy to Jury: The Pharmacological Basis for the Use of Shikonin as an Anticancer Therapy
Current Medicinal Chemistry Detection of Lysyl Oxidase-Like 2 (LOXL2), a Biomarker of Metastasis from Breast Cancers Using Human Blood Samples
Recent Patents on Biomarkers Regulation of HIPK Proteins by MicroRNAs
MicroRNA Molecular Mechanisms and Therapeutic Application of NSAIDs and Derived Compounds in Alzheimers Disease
Current Alzheimer Research Arsenic-exposed Keratinocytes Exhibit Differential microRNAs Expression Profile; Potential Implication of miR-21, miR-200a and miR-141 in Melanoma Pathway
Clinical Cancer Drugs Targeting 5-Lipoxygenase for Prevention and Treatment of Cancer
Current Enzyme Inhibition Platelets in Alzheimer’s Disease-Associated Cellular Senescence and Inflammation
Current Pharmaceutical Design Transcription/Expression of KLRB1 Gene as A Prognostic Indicator in Human Esophageal Squamous Cell Carcinoma
Combinatorial Chemistry & High Throughput Screening Lipid-based Nanocarriers As An Alternative for Oral Delivery of Poorly Water- Soluble Drugs: Peroral and Mucosal Routes
Current Medicinal Chemistry Non-invasive Biodiversified Sensors: A Modernized Screening Technology for Cancer
Current Pharmaceutical Design Expression, Purification and Auto-Activation of Cathepsin E from Insect Cells
Protein & Peptide Letters The Current WHO Classification of Tumours of the Central Nervous System: Histopathology and Additional Diagnostic Methods
Current Medical Imaging Chemokine Like Receptor-1 (CMKLR-1) Receptor: A Potential Therapeutic Target in Management of Chemerin Induced Type 2 Diabetes Mellitus and Cancer
Current Pharmaceutical Design Bruton's Tyrosine Kinase Inhibition in the Treatment of Preclinical Models and Multiple Sclerosis
Current Pharmaceutical Design Angiogenesis as a Therapeutic Target in Arthritis: Lessons from Oncology
Current Pharmaceutical Design